Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Industry: Pharmaceutical

Add a new term

Contributors in Cancer drugs

Become a Contributors

Cancer drugs

Recombinant interleukin-12

Pharmaceutical; Cancer drugs

A recombinant form of the endogenous heterodimeric cytokine interleukin-12 with potential antineoplastic activity. Recombinant interleukin-12 binds to and activates its cell-surface receptor, ...

Recombinant PRAME protein plus AS15 adjuvant GSK2302025A

Pharmaceutical; Cancer drugs

A recombinant form of the human PRAME (Preferentially Expressed Antigen of Melanoma) protein combined with the AS15 adjuvant, with potential immunostimulatory and antineoplastic activities. Upon ...

Adecatumumab

Pharmaceutical; Cancer drugs

A recombinant human IgG1 monoclonal antibody (MoAb) directed against the tumour associated antigen (TAA) epithelial cell adhesion molecule (EpCAM) with potential antitumor activity. Adecatumumab ...

Recombinant soluble human CD4 protein

A recombinant human soluble CD4 with antiviral activity. Recombinant human soluble CD4 has the amino terminus but not the T-cell binding domain of the endogenous CD4 antigen. This soluble CD4 protein ...

Dulanermin

Pharmaceutical; Cancer drugs

A recombinant human soluble protein corresponding to amino acids 114-281 of the Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand (RhApo2L/TRAIL) with potential antineoplastic ...

Anti-EGFRvIII immunotoxin MR1-1

Pharmaceutical; Cancer drugs

A recombinant immunotoxin consisting of single-chain variable domain fragment antibody directed against the tumor-specific antigen EGFRvIII (MR1scFv) fused to domains II and III of the Pseudomonas ...

RFT5-dgA immunotoxin

Pharmaceutical; Cancer drugs

A recombinant immunotoxin consisting of the anti-CD25 monoclonal antibody RFT5 fused to the deglycosylated ricin A-chain (dgA) with potential antitumor activity. The monoclonal antibody moiety of ...